Our leadership
Learn more
Christopher’s practice spans venture capital, private equity, M&A, banking and capital markets, finance, and general corporate law. He represents clients in transactions involving international investors, as well as start-ups/scale-ups and other companies (both public and private), particularly in the health care, life sciences, and technology sectors. He also advises banks and financial services providers on banking and capital markets matters.
Experience
Representative matters
Representative matters
Advised FinTech start-up Aufinity, headquartered in Cologne and operating in the automotive sector, on a Series C financing round.
Advised the medical technology manufacturer Coldplasmatech GmbH on an equity financing and associated strategic investment by the U.S. company Royal Biologics.
Led a cross-border team of more than 100 lawyers from eight jurisdictions in providing full-scope advice to International Chemical Investors Group (ICIG) on the acquisition of the compounds business of Benvic Group SAS from PVC Europe Group S.a.r.l., an independently managed investment subsidiary of Investindustrial Growth L.P.
Representative Experience
Advised FinTech start-up Aufinity, headquartered in Cologne and operating in the automotive sector, on a Series C financing round.
Advised the medical technology manufacturer Coldplasmatech GmbH on an equity financing and associated strategic investment by the U.S. company Royal Biologics.
Led a cross-border team of more than 100 lawyers from eight jurisdictions in providing full-scope advice to International Chemical Investors Group (ICIG) on the acquisition of the compounds business of Benvic Group SAS from PVC Europe Group S.a.r.l., an independently managed investment subsidiary of Investindustrial Growth L.P.
Advised South Korean Yonsung Group on its acquisition of German-based pharmaceutical manufacturer Arevipharma GmbH.
Advised biopharmaceutical company Immunic AG on a reverse merger with Nasdaq-listed Vital Therapies, Inc.
Advised biopharmaceutical company Immunic on a financing agreement of up to €24.5 million to support the development of a potential COVID-19 treatment.
Advised shareholders of leading German multiplex cytometry provider Zellkraftwerk GmbH on the sale of their shares to Canopy Biosciences, a leading provider of gene editing and gene expression products and services.
Advised French sanitary manufacturer SFA-Sanibroy on the strategic acquisition of Zehnder Pumpen.
Advised Switzerland-based software company Contentserv Group on a significant investment by Investcorp Technology Partners, a leading investor in the European mid-market technology sector.
Advised Fidelio Healthcare on the takeover of Mundipharma's production site in Limburg, Germany.
Structured an AIFM and special AIF investing in cryptocurrency.
Advised a German hedge fund on its conversion into a self-managed AIF and sub-threshold AIFM.
Credentials
Education
Education
- University of Bayreuth, 2003, Legal studies with supplementary economics training
Professional admissions & qualifications
Professional admissions & qualifications
- Germany